ISMPP 2025-Voice of Patients, Patient Voice

“Voice of Patient” in Publications: Trends and Perspectives

This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication Professionals), which took place May 12-14, 2025. Authors and affiliations Authors: Swapna Ganduri, Jeenu Jacob, Ruchika Agrawal, Nilima Vyas, Charvin D'souza, and Namita Bose Affiliation: Cactus Life Sciences, Mumbai, India Abstract Objective: Power of the patient voice can significantly improve patients’…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging technology for patient centricity

Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs

As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...
Clinical Trial Pain Points

Pharma, Physician, and Patient Pain Points Regarding Clinical Trials

Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
FINAL Clinical Trial Summaries Blog-Banner-810x540

Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?

A majority of patients feel lay summaries for clinical trials are very important and won’t...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.